Aljas, Rosefe D.
HRN: 12-49-28 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2023
CEFUROXIME 500MG (TAB)
03/16/2023
03/23/2023
ORAL
500mg
BID
Thinly MSAF
Waiting Final Action